Tine S Meyhoff
Overview
Explore the profile of Tine S Meyhoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sivapalan P, Ellekjaer K, Jessen M, Meyhoff T, Cronhjort M, Hjortrup P, et al.
Chest
. 2023 May;
164(4):892-912.
PMID: 37142091
Background: IV fluids are recommended for adults with sepsis. However, the optimal strategy for IV fluid management in sepsis is unknown, and clinical equipoise exists. Research Question: Do lower vs ...
2.
Meyhoff T, Wichmann S, Messmer A
Front Med (Lausanne)
. 2023 Mar;
10:1166202.
PMID: 36936240
No abstract available.
3.
Meyhoff T, Sivapalan P, Perner A
N Engl J Med
. 2022 Sep;
387(9):857.
PMID: 36053521
No abstract available.
4.
Meyhoff T, Hjortrup P, Wetterslev J, Sivapalan P, Laake J, Cronhjort M, et al.
N Engl J Med
. 2022 Jun;
386(26):2459-2470.
PMID: 35709019
Background: Intravenous fluids are recommended for the treatment of patients who are in septic shock, but higher fluid volumes have been associated with harm in patients who are in the...
5.
Sivapalan P, Meyhoff T, Hjortrup P, Lange T, Moller M, Perner A, et al.
Acta Anaesthesiol Scand
. 2022 Mar;
66(6):767-771.
PMID: 35338648
Background: Clinical equipoise exists regarding intravenous (IV) fluid volumes in sepsis. The Conservative vs. Liberal Approach to fluid therapy of Septic Shock in Intensive Care (CLASSIC) trial investigates the effect...
6.
Munch M, Myatra S, Vijayaraghavan B, Saseedharan S, Benfield T, R Wahlin R, et al.
JAMA
. 2021 Oct;
326(18):1807-1817.
PMID: 34673895
Importance: A daily dose with 6 mg of dexamethasone is recommended for up to 10 days in patients with severe and critical COVID-19, but a higher dose may benefit those...
7.
Schjorring O, Lange T, Krag M, Andersen-Ranberg N, Meyhoff T, Marker S, et al.
Acta Anaesthesiol Scand
. 2021 Oct;
66(1):156-162.
PMID: 34606090
Background: Intensive care unit (ICU) patients receive numerous interventions, but knowledge about potential interactions between these interventions is limited. Co-enrolment in randomized clinical trials represents a unique opportunity to investigate...
8.
Barbateskovic M, Koster T, Eck R, Maagaard M, Afshari A, Blokzijl F, et al.
J Clin Epidemiol
. 2021 Feb;
135:29-41.
PMID: 33561529
Objective: To develop and validate Clinical Diversity In Meta-analyses (CDIM), a new tool for assessing clinical diversity between trials in meta-analyses of interventions. Study Design And Setting: The development of...
9.
Kjaer M, Meyhoff T, Madsen M, Hjortrup P, Moller M, Egerod I, et al.
Acta Anaesthesiol Scand
. 2019 Dec;
64(3):410-416.
PMID: 31828753
Background: In patients with septic shock, mortality is high, and survivors experience long-term physical, mental and social impairments. The ongoing Conservative vs Liberal Approach to fluid therapy of Septic Shock...
10.
Krag M, Marker S, Perner A, Wetterslev J, Wise M, Schefold J, et al.
N Engl J Med
. 2018 Oct;
379(23):2199-2208.
PMID: 30354950
Background: Prophylaxis for gastrointestinal stress ulceration is frequently given to patients in the intensive care unit (ICU), but its risks and benefits are unclear. Methods: In this European, multicenter, parallel-group,...